Stephen Huhn
CMO and SVP, Clinical Development at Pipeline Therapeutics - San Diego, California, United States
Stephen Huhn's Colleagues at Pipeline Therapeutics
Stephen Huhn's Contact Details
San Francisco,California,United States
Pipeline Therapeutics
Stephen Huhn's Company Details
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company's lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. The company also has a portfolio of programs, including PIPE-307, focused on remyelination and axonal repair, to address a range of neurological disorders, including multiple sclerosis.